Category: Pipeline & Product Deep Dives

Mask Group (20)

Patent Milestone and Stability Data Strengthen Licensing Value of SJP-002C

One year ago, we filed a provisional patent application for our Upper Respiratory Infection Therapeutic – SJP-002C, covering the novel manufacturing process for our dual-acting oral therapy…
Read More
Mask Group (18)

Sen-Jam Pharmaceutical Answers Surgeon General’s Alarm with a New Therapeu...

HUNTINGTON, N.Y., Jan. 27, 2025 /PRNewswire/ — A newly published paper in the Global Journal of Addiction & Rehabilitation Medicine further expands on the U.S. Surgeon General’s advisory, linking frequent alcohol…
Read More
Preliminary Positive Results 1 Scaled 1

Sen-Jam Pharmaceutical Announces Preliminary Results from Phase 2 Clinical Trial...

HUNTINGTON, N.Y., Jan. 15, 2025 /PRNewswire/ — Sen-Jam Pharmaceutical is excited to announce the preliminary results from its recently completed Phase 2 clinical trial evaluating the safety and efficacy of SJP-002C…
Read More
Encouragement Original 534082 Scaled 1 1 (1)

Sen-Jam Pharmaceutical Announces Ethics Approval in Australia for SJP-001 Clinic...

HUNTINGTON, N.Y., Jan. 14, 2025 /PRNewswire/ — Sen-Jam Pharmaceutical, a leader in developing innovative solutions to address inflammation at its root cause, proudly announces that its flagship asset, SJP-001…
Read More
Top View Of Female Hands Holding Cup Of Hot Tea Original 2740162 Min 1 1

Sen-Jam Pharmaceutical Files Groundbreaking Patent for Novel Therapeutic Approac...

HUNTINGTON, N.Y., Jan. 9, 2025 /PRNewswire/ — Sen-Jam Pharmaceutical, a leader in innovative anti-inflammatory care, today announced the submission of a new patent application that introduces…
Read More

Where the Next Spark Becomes Tomorrow’s Headline

 

Our newsroom of scientists, strategists, and culture-watchers tracks the earliest pulses in biology, policy, and public conversation—translating fresh data into actionable perspective before the rest of pharma blinks. Stay tuned, stay sharp, and stay upstream with us.

Subscribe for Fresh Signals
MEDIA INQUIRIES

Media Inquiry